NMT Medical Inc., a Boston provider of cardiac implants, is moving its securities trading to the OTCQB, following the company’s 2010 notice that it failed to meet the minimum requirements to trade on the Nasdaq Capital Market. Trading on the OTCQB will begin Feb. 7, with NMT Medical retaining its ticker symbol “NMTI”.
NMT Medical officials said the company decided not to appeal the Nasdaq delisting decision.
SOURCE